Mod GRF, Ipamorelin 10mg (Blend)
$95.00
Mod GRF and Ipamorelin is a research peptide blend designed to explore synergistic GHRH and ghrelin receptor activation. Mod GRF (CJC-1295 no DAC) binds to the GHRH receptor, activating cAMP/PKA signaling for GH synthesis, while Ipamorelin stimulates GHS-R1a via Gq/11-mediated calcium release. This combination serves as a preclinical model for investigating peptide receptor dynamics, pulsatile secretion, and endocrine modulation.
For research use only. Not for human consumption.
References:
Teichman SL et al., J Clin Endocrinol Metab, 2006 91(2):479–487
Bowers CY et al., Endocrinology, 1990 126(2):1165–1171
Kojima M et al., Nature, 1999 402(6762):656–660
Modified GRF 5mg, Ipamorelin 5mg (10mg Total Blend)
RUO Disclaimer
The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
For Laboratory Research Only. Not for human use, medical use, diagnostic use, or veterinary use.
